- Home
- DTIL vs PRT Comparison
DTIL vs PRT Comparison
Compare DTIL & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- PRT
- Stock Information
- Founded
- DTIL 2006
- PRT 2017
- Country
- DTIL United States
- PRT United States
- Employees
- DTIL N/A
- PRT N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- PRT Oil & Gas Production
- Sector
- DTIL Health Care
- PRT Energy
- Exchange
- DTIL Nasdaq
- PRT Nasdaq
- Market Cap
- DTIL 55.3M
- PRT 47.7M
- IPO Year
- DTIL 2019
- PRT N/A
- Fundamental
- Price
- DTIL $5.44
- PRT $3.94
- Analyst Decision
- DTIL Strong Buy
- PRT
- Analyst Count
- DTIL 2
- PRT 0
- Target Price
- DTIL $47.00
- PRT N/A
- AVG Volume (30 Days)
- DTIL 93.0K
- PRT 37.2K
- Earning Date
- DTIL 11-03-2025
- PRT 11-12-2025
- Dividend Yield
- DTIL N/A
- PRT 10.67%
- EPS Growth
- DTIL N/A
- PRT 1.16
- EPS
- DTIL N/A
- PRT 0.44
- Revenue
- DTIL $1,261,000.00
- PRT $6,314,770.00
- Revenue This Year
- DTIL N/A
- PRT N/A
- Revenue Next Year
- DTIL $135.19
- PRT N/A
- P/E Ratio
- DTIL N/A
- PRT $8.97
- Revenue Growth
- DTIL N/A
- PRT 1.82
- 52 Week Low
- DTIL $3.61
- PRT $3.26
- 52 Week High
- DTIL $9.81
- PRT $4.63
- Technical
- Relative Strength Index (RSI)
- DTIL 62.03
- PRT 51.24
- Support Level
- DTIL $5.26
- PRT $3.84
- Resistance Level
- DTIL $5.56
- PRT $3.89
- Average True Range (ATR)
- DTIL 0.22
- PRT 0.08
- MACD
- DTIL 0.06
- PRT 0.01
- Stochastic Oscillator
- DTIL 88.68
- PRT 67.39
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.